Researchers from the University of Miami have discovered that injections of cardiac stem cells and mesenchymal stem cells can radically improve cardiac performance following a heart attack. The combination of both cell types is thought to provide a stronger and more effective treatment for patients with heart failure.
The experimental group received transendocardial injections of c-kit+ cardiac stem cells (CSCs) and mesenchymal stem cells (MSCs). The tissues exhibited a reduction in scar size, improved contractile performance, and increased formation of cardiomyocytes. The combined cell therapy continued to show significant cardiac enhancement for at least three months post treatment.
For the millions of Americans dealing with heart failure and severe cardiac damage this combined cell therapy represents a huge breakthrough, likely to increase survival and quality of life. These findings illustrate that interactions between MSCs and CSCs enhance cardiac performance more than MSCs alone, and establish the safety of autologous cell combination strategies. Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™.
To view the full article, click here.